These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
338 related articles for article (PubMed ID: 8524836)
1. Crystal structure of the complex of a catalytic antibody Fab fragment with a transition state analog: structural similarities in esterase-like catalytic antibodies. Charbonnier JB; Carpenter E; Gigant B; Golinelli-Pimpaneau B; Eshhar Z; Green BS; Knossow M Proc Natl Acad Sci U S A; 1995 Dec; 92(25):11721-5. PubMed ID: 8524836 [TBL] [Abstract][Full Text] [Related]
2. Crystal structure of a catalytic antibody Fab with esterase-like activity. Golinelli-Pimpaneau B; Gigant B; Bizebard T; Navaza J; Saludjian P; Zemel R; Tawfik DS; Eshhar Z; Green BS; Knossow M Structure; 1994 Mar; 2(3):175-83. PubMed ID: 8069632 [TBL] [Abstract][Full Text] [Related]
3. A comparison of the crystallographic structures of two catalytic antibodies with esterase activity. Buchbinder JL; Stephenson RC; Scanlan TS; Fletterick RJ J Mol Biol; 1998 Oct; 282(5):1033-41. PubMed ID: 9753552 [TBL] [Abstract][Full Text] [Related]
4. A structural basis for transition-state stabilization in antibody-catalyzed hydrolysis: crystal structures of an abzyme at 1. 8 A resolution. Kristensen O; Vassylyev DG; Tanaka F; Morikawa K; Fujii I J Mol Biol; 1998 Aug; 281(3):501-11. PubMed ID: 9698565 [TBL] [Abstract][Full Text] [Related]
5. High-resolution crystal structure of the Fab-fragments of a family of mouse catalytic antibodies with esterase activity. Ruzheinikov SN; Muranova TA; Sedelnikova SE; Partridge LJ; Blackburn GM; Murray IA; Kakinuma H; Takahashi-Ando N; Shimazaki K; Sun J; Nishi Y; Rice DW J Mol Biol; 2003 Sep; 332(2):423-35. PubMed ID: 12948492 [TBL] [Abstract][Full Text] [Related]
6. Structural convergence in the active sites of a family of catalytic antibodies. Charbonnier JB; Golinelli-Pimpaneau B; Gigant B; Tawfik DS; Chap R; Schindler DG; Kim SH; Green BS; Eshhar Z; Knossow M Science; 1997 Feb; 275(5303):1140-2. PubMed ID: 9027317 [TBL] [Abstract][Full Text] [Related]
7. A comparative analysis of the immunological evolution of antibody 28B4. Yin J; Mundorff EC; Yang PL; Wendt KU; Hanway D; Stevens RC; Schultz PG Biochemistry; 2001 Sep; 40(36):10764-73. PubMed ID: 11535051 [TBL] [Abstract][Full Text] [Related]
8. Structural basis for antibody catalysis of a cationic cyclization reaction. Zhu X; Heine A; Monnat F; Houk KN; Janda KD; Wilson IA J Mol Biol; 2003 May; 329(1):69-83. PubMed ID: 12742019 [TBL] [Abstract][Full Text] [Related]
9. Structural basis for a disfavored elimination reaction in catalytic antibody 1D4. Larsen NA; Heine A; Crane L; Cravatt BF; Lerner RA; Wilson IA J Mol Biol; 2001 Nov; 314(1):93-102. PubMed ID: 11724535 [TBL] [Abstract][Full Text] [Related]
10. Mechanism of inactivation of a catalytic antibody by p-nitrophenyl esters. Gigant B; Charbonnier JB; Golinelli-Pimpaneau B; Zemel RR; Eshhar Z; Green BS; Knossow M Eur J Biochem; 1997 Jun; 246(2):471-6. PubMed ID: 9208940 [TBL] [Abstract][Full Text] [Related]
11. Structure and specificity of the anti-digoxin antibody 40-50. Jeffrey PD; Schildbach JF; Chang CY; Kussie PH; Margolies MN; Sheriff S J Mol Biol; 1995 Apr; 248(2):344-60. PubMed ID: 7739045 [TBL] [Abstract][Full Text] [Related]
12. Crossreactivity, efficiency and catalytic specificity of an esterase-like antibody. Gigant B; Charbonnier JB; Eshhar Z; Green BS; Knossow M J Mol Biol; 1998 Dec; 284(3):741-50. PubMed ID: 9826512 [TBL] [Abstract][Full Text] [Related]
13. Catalysis of decarboxylation by a preorganized heterogeneous microenvironment: crystal structures of abzyme 21D8. Hotta K; Lange H; Tantillo DJ; Houk KN; Hilvert D; Wilson IA J Mol Biol; 2000 Oct; 302(5):1213-25. PubMed ID: 11183784 [TBL] [Abstract][Full Text] [Related]
14. Mechanistically different catalytic antibodies obtained from immunization with a single transition-state analog. Guo J; Huang W; Zhou GW; Fletterick RJ; Scanlan TS Proc Natl Acad Sci U S A; 1995 Feb; 92(5):1694-8. PubMed ID: 7878042 [TBL] [Abstract][Full Text] [Related]
15. Structural evidence for a programmed general base in the active site of a catalytic antibody. Golinelli-Pimpaneau B; Goncalves O; Dintinger T; Blanchard D; Knossow M; Tellier C Proc Natl Acad Sci U S A; 2000 Aug; 97(18):9892-5. PubMed ID: 10963661 [TBL] [Abstract][Full Text] [Related]
16. Evolution of shape complementarity and catalytic efficiency from a primordial antibody template. Xu J; Deng Q; Chen J; Houk KN; Bartek J; Hilvert D; Wilson IA Science; 1999 Dec; 286(5448):2345-8. PubMed ID: 10600746 [TBL] [Abstract][Full Text] [Related]
17. How the anti-(metal chelate) antibody CHA255 is specific for the metal ion of its antigen: X-ray structures for two Fab'/hapten complexes with different metals in the chelate. Love RA; Villafranca JE; Aust RM; Nakamura KK; Jue RA; Major JG; Radhakrishnan R; Butler WF Biochemistry; 1993 Oct; 32(41):10950-9. PubMed ID: 8218161 [TBL] [Abstract][Full Text] [Related]
18. Crystal structure of a catalytic antibody with a serine protease active site. Zhou GW; Guo J; Huang W; Fletterick RJ; Scanlan TS Science; 1994 Aug; 265(5175):1059-64. PubMed ID: 8066444 [TBL] [Abstract][Full Text] [Related]
19. Three-dimensional structures of the Fab fragment of murine N1G9 antibody from the primary immune response and of its complex with (4-hydroxy-3-nitrophenyl)acetate. Mizutani R; Miura K; Nakayama T; Shimada I; Arata Y; Satow Y J Mol Biol; 1995 Nov; 254(2):208-22. PubMed ID: 7490744 [TBL] [Abstract][Full Text] [Related]
20. 26-10 Fab-digoxin complex: affinity and specificity due to surface complementarity. Jeffrey PD; Strong RK; Sieker LC; Chang CY; Campbell RL; Petsko GA; Haber E; Margolies MN; Sheriff S Proc Natl Acad Sci U S A; 1993 Nov; 90(21):10310-4. PubMed ID: 8234291 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]